logo
#

Latest news with #DrugsandMagicRemedies

Ramdev's Patanjali under probe for suspicious transactions, faces govt scrutiny
Ramdev's Patanjali under probe for suspicious transactions, faces govt scrutiny

Business Standard

time5 days ago

  • Business
  • Business Standard

Ramdev's Patanjali under probe for suspicious transactions, faces govt scrutiny

The Centre has asked Patanjali Ayurved Ltd to explain a series of financial transactions flagged as suspicious by federal economic intelligence agencies, according to a report by Bloomberg. The Ministry of Corporate Affairs has issued a notice to the firm and is probing potential fund diversion and breaches of corporate governance. The flagged transactions of yoga guru Ramdev's company were deemed 'abnormal and dubious', though specific figures have not been disclosed, as the investigation remains at a preliminary stage. Patanjali has been given roughly two months to respond to the ministry's notice. Patanjali Ayurved continues to face regulatory scrutiny This latest scrutiny adds to the growing list of legal and regulatory challenges faced by Patanjali Ayurved and its affiliates. Last year, a unit of the company received show-cause notices over alleged tax violations and wrongful refund claims. Moreover, the traditional medicine company faced significant backlash for promoting misleading ads on products, promising cures for serious medical ailments such as cancer. The Supreme Court had restrained the company from promoting its products as cures for various ailments, citing violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. In February 2025, the Kerala Drugs Control Department reported 26 active cases across various courts in the state against Ramdev and Patanjali under the same advertisement law. Several newspapers also face legal proceedings for publishing the disputed advertisements. While Patanjali Ayurved remains privately held, its listed subsidiary, Patanjali Foods Ltd, has felt the impact. Its shares have dropped nearly 10 per cent so far this month.

Five years on, proposal to amend act on misleading ads still on hold: RTI
Five years on, proposal to amend act on misleading ads still on hold: RTI

New Indian Express

time19-05-2025

  • Health
  • New Indian Express

Five years on, proposal to amend act on misleading ads still on hold: RTI

NEW DELHI: Five years ago, the Union Health Ministry proposed significant changes to amend the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, which aimed to take stringent action against misleading advertisements, including those of Ayush medicines. However, an RTI has revealed that the ministry seems to have kept it in cold storage, as there has been no movement after November 2022. The amendments to the DMR (Objectionable Advertisement) Act, 1954, proposed widening the scope of the Act by introducing 24 more diseases and disorders, including drugs for treatment for enhancing sexual performance, and fairness of skin. The act applies to all drugs, including Ayurvedic, Siddha, Unani, and Homoeopathy medicines. Replying to an RTI filed by activist, Dr KV Babu, the Union Health Ministry on May 15 said, 'As per available records, no noting has been recorded after 09/11/2022 in File No A.11035/133/2014-DFQC.' The Kerala-based ophthalmologist said, 'The draft proposal was put on the public domain in February 2020 following criticism of Parliamentary Standing Committee in 2018. Instead of 54 diseases, the scope was widened to 78 diseases and disorders and the punishment was enhanced to two years and five years, instead of six months and one year.' 'The proposed amendment has been under suspended animation for more than five years, and there is no file movement after November 2022,' he said.

DCA seizes syrup stocks over misleading fever cure claim
DCA seizes syrup stocks over misleading fever cure claim

The Hindu

time15-05-2025

  • Health
  • The Hindu

DCA seizes syrup stocks over misleading fever cure claim

Officials from the Telangana Drugs Control Administration (DCA) have seized stocks of a syrup marketed as a cure for 'all types of fevers', citing violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. During a raid conducted on May 14 at a medical store in Adilabad, the DCA officers found the product, 'Herbal Fever Guard Syrup' being sold with a label that falsely claimed it could treat all types of fevers. The medicine is manufactured and marketed by International Herbal Corporation Private Limited, based in Haridwar, Uttarakhand, said a release. Authorities said the product's label amounts to a misleading advertisement, which is prohibited under the 1954 Act. The law explicitly bans advertisements that promote medicines as treatments for certain diseases and conditions, including fevers in general. As per the Act, no person is allowed to participate in the publication or circulation of such advertisements. Stocks of the syrup were seized on the spot, and further investigation is underway, the release stated.

Punjab influencer denied bail after 71 suffer adverse reactions to hair oil for baldness
Punjab influencer denied bail after 71 suffer adverse reactions to hair oil for baldness

Indian Express

time15-05-2025

  • Health
  • Indian Express

Punjab influencer denied bail after 71 suffer adverse reactions to hair oil for baldness

The Punjab and Haryana High Court has denied anticipatory bail to a social media influencer who promoted a homemade hair growth oil that allegedly caused adverse reactions in more than 70 people during a camp in Punjab's Sangrur. The incident took place on March 16 at the Kali Mata Temple in Sangrur, where Amandeep Singh applied his oil on attendees, claiming it could combat baldness. Within hours, 71 people reported burning sensations in the eyes and swelling on their faces. They were treated at Civil Hospital, Sangrur, where the senior medical officer diagnosed the reaction as severe contact dermatitis. Doctors warned that if the eyes' corneas had been affected, some victims could have lost their vision. Singh, who has more than 86,000 followers online and has applied for a patent for the oil, claimed the reactions were due to improper application by the users. His counsel highlighted his work as a hairstylist, and said he was only trying to help people facing hair loss. The court, however, was not persuaded. Citing the scale of the reactions — around 500 people had attended the event — the judge noted that the case pointed to broader dangers of unverified beauty products being marketed on social media. In a strongly worded order delivered on May 12, the court criticised the role of online influencers in exploiting personal insecurities for profit. Quoting Shakespeare — 'Love looks not with the eyes, but with the mind; and therefore is winged Cupid painted blind' — the judge said, 'This is yet another unfortunate example of internet-famous, unqualified quacks taking advantage of the common man's insecurities.' The court stressed that products should be released only after ensuring safety and understanding possible side effects. 'Advertising tall, misleading claims without scientific backing must be condemned,' the judge said, adding that the state had a responsibility to protect public health and maintain trust in the market. With the bail plea dismissed, Singh now faces arrest as the investigation continues under charges including Section 124 of the Bharatiya Nyaya Sanhita (BNS), 2023, and Section 7 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store